Fuel up with Bigmuscles Nutrition: Amazon Sale offers up to 45% off on protein powders, creatine and other supplements
Sports supplements can enhance exercise and athletic performance. In fact, more than two-thirds of 3,887 adult and adolescent elite track and field athletes competing in the world championship events reported using one or more dietary supplements, typically containing ingredients like vitamins, minerals, creatine, caffeine, and amino acids (Source: National Institutes of Health, U.S. Department of Health & Human Services).
It is a powerhouse blend of whey isolate and ProHydrolase Enzyme Technology. This best protein powder delivers 25g of protein and 11g of EAAs per scoop for maximum absorption, faster recovery, and muscle growth. Certified by Informed Choice UK and free from amino spiking, it is ideal for anyone serious about results. Moreover, this whey protein's delicious mango flavour and superior digestibility make it your go-to daily protein for anytime use.
Bigmuscles Nutrition Premium Gold Whey [1Kg] | Informed Choice UK Certified | Isolate Whey Protein Blend | 25g Protein | 11g EAA | ProHydrolase Enzyme Technology [Mango Magic]
Designed for clean bulking, Real Mass Gainer packs 1000 calories with 50g protein from 5 sources and 160g complex carbs per 3 servings. It contains 7500mg BCAAs and 3000mg glutamine to support muscle growth, recovery, and metabolism. Perfect for teens, athletes, or gym-goers looking to gain mass the healthy way, this best mass gainer blends into shakes, smoothies, or recipes for a delicious calorie boost.
Bigmuscles Nutrition Real Mass Gainer [1Kg,Mango Magic]|Lean Whey Protein Muscle Mass Gainer|Complex Carbohydrates,|1000 Calories|Reduces Muscle Breakdown|Boosts Metabolism,1 count,13 servings
This vegan-friendly, micronized BCAA powder delivers 5g of amino acids per serving to fuel endurance, support muscle recovery, and reduce fatigue. Real BCAA helps your body bounce back faster after intense training while preparing you for the next. With refreshing flavours and zero caffeine, this best BCAA supplement is keto-friendly and suitable for any workout style.
ALSO READ: Best iron supplements for anemia: 10 picks to restore vitality and fight deficiency
Bigmuscles Nutrition Real BCAA [90 Servings, Blueberry] -100% Micronized Vegan, Muscle Recovery & Endurance BCAA Powder, 5 Grams of Amino Acids, Keto Friendly, Caffeine Free
Kickstart your fitness journey with this all-in-one whey protein blend. Packed with 24g of protein, digestive enzymes, vitamins, and minerals, this best whey protein supports energy, muscle repair, and recovery. Tested for banned substances and developed after a decade of research, Essential Whey comes in indulgent flavours like strawberry milkshake and Dutch chocolate.
Bigmuscles Nutrition Essential Whey Protein 1Kg [Strawberry Milkshake] | 24g Protein per serving with Digestive Enzymes, Vitamin & Minerals,No Added Sugar|Strength, Faster Recovery & Muscle Building
FREAK is not your average pre-workout supplement, it is an intense, research-driven formula with 5 powerful matrices for explosive energy, sharper focus, muscle pumps, and endurance. Designed to elevate cognitive function and delay fatigue, it is your ultimate fuel for high-performance training. Whether you are pushing for one more rep or sprint, this best pre-workout supplement helps you stay dialed in and dominate your workout.
Bigmuscles Nutrition Freak Pre-Workout Sydney Sunset [60 Servings, 360g]
This micronized creatine monohydrate is designed to boost ATP production, promote muscle repair, and enhance strength and endurance. With superior absorption and faster bioavailability, this best creatine supplement helps you train harder, recover faster, and gain lean muscle. Mix 1 scoop with water and consume pre- or post-workout. Suitable for all, from beginners to powerlifters, this creatine is essential for your gym bag.
ALSO READ: Unflavoured whey protein: 10 top-rated options for pure and effective nutrition in 2025
Bigmuscles Nutrition Creatine [257g, 83 Servings] | Sex On The Beach | Micronized Creatine Monohydrate To Support Lean Muscle Repair & Recovery, powder, 1 count
Power your pump with 2000mg of Citrulline Malate per scoop. This potent nitric oxide booster enhances vascularity, delays fatigue, and supports peak muscle performance. Whether you are lifting heavy or doing high-intensity training, Citrulline Malate helps you feel the burn and go beyond it. Enjoy its juicy mango flavour as a delicious pre-workout kick that supports explosive strength and recovery.
Bigmuscles Nutrition Citrulline Malate [50 Servings, Mango Madness]|2000 Mg|Pre Workout Powder|Enhance Muscle Pumps|Improve Muscle Vascularity|Nitric Oxide Booster| 100 Gm
Fuel intense training with Nitra Isolate, delivering a whopping 32g of protein and 10g of EAAs per scoop. Powered by fast-absorbing whey isolate and ProHydrolase Enzyme Tech, it ensures superior muscle growth, reduced soreness, and quicker recovery. The Rich Chocolate flavour makes every serving feel indulgent.
Bigmuscles Nutrition Nitra Isolate [1kg, Rich Chocolate] | 32g Protein | 10g EAA | Whey Protein with ProHydrolase Enzyme Tech. For Faster Absorption | Improved Strength, Faster Recovery & Muscle Building
Dietary supplements like protein powder, creatine, mass gainers, BCAAs, and pre-workouts support muscle growth, recovery, and performance. Protein powders provide essential amino acids to build and repair muscles. Creatine boosts strength, power, and endurance by enhancing ATP production. Mass gainers supply extra calories and nutrients for healthy weight gain. BCAAs reduce muscle soreness and fatigue while improving recovery. Pre-workouts increase energy, focus, and stamina, helping you push harder during workouts for better results. Together, they optimize fitness progress safely.
A few more options for you:
Avvatar vs MuscleBlaze: Which one offers the best whey protein for muscle growth
Best 5 kg dumbbell sets for beginners: Start your fitness journey with these top picks of 2025
Protein supplement for gym: Build lean muscle and recover fast with these 10 top-rated picks
It combines whey isolate and ProHydrolase enzyme for superior absorption, delivering 25g of protein and 11g of EAAs per scoop, certified by Informed Choice UK and free from amino spiking.
It is ideal for teens, athletes, and gym-goers who need clean bulking support with 1000 calories, 50g protein, complex carbs, BCAAs, and glutamine to boost muscle growth and metabolism.
Freak features 5 energy, focus, endurance, and pump-boosting matrices. This may enhance cognitive function and delay fatigue to help you push harder and dominate high-intensity workouts.
Yes, micronized creatine supports strength, endurance, and muscle repair. It is suitable for everyone from beginners to powerlifters, with faster absorption for optimal training and recovery results.
Disclaimer: At Hindustan Times, we help you stay up-to-date with the latest trends and products. Hindustan Times has an affiliate partnership, so we may get a part of the revenue when you make a purchase. We shall not be liable for any claim under applicable laws, including but not limited to the Consumer Protection Act, 2019, concerning the products. The products listed in this article are in no particular order of priority.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
2 days ago
- Time of India
US scientists discover common virus that can cause skin cancer
Representational image You've probably heard of HPV—the virus most people think of when it comes to things like cervical cancer. But did you know there's a type of HPV that usually just lives on your skin, minding its own business? It's called beta-HPV, and until now, scientists thought it didn't directly cause skin cancer. They believed it only helped skin damage from sun exposure get worse over time. Well, here's the twist: Researchers at the National Institutes of Health (NIH) found proof that this 'harmless' beta-HPV can actually turn into a full-on cause of skin cancer—but especially in people whose immune systems aren't working right. The story starts with a 34-year-old woman who kept getting a common type of skin cancer called squamous cell carcinoma on her forehead. Despite surgeries and treatments, the cancer kept coming back. Doctors first thought her skin couldn't repair sun damage properly and that her immune system was letting the virus run wild. Turns out, in her case, the beta-HPV virus actually sneaked into the DNA of her skin cells and was actively producing viral proteins basically hijacking her skin cells. This was big news because before, beta-HPV wasn't known to do that. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Spacious 3 & 4 BHK Homes Starting ₹1.65 Cr Near HITEC City Honer Signatis Book Now Undo Her immune system's problem was that certain immune cells, T cells, weren't activating well enough to fight off the virus. Because of this, the virus stuck around and caused the skin cancer to come back again and again. So what did the NIH team do? They created a personalized treatment plan and gave her a stem cell transplant to replace her faulty immune cells with healthy ones. After the transplant, all her HPV-related issues, including the skin cancer, disappeared and haven't come back in over three years. This case shows that in people with weakened immune defenses, beta-HPV can directly cause skin cancer by hijacking skin cells, rather than just helping sun damage do its thing. Scientists say this discovery could change how skin cancer, especially this kind, gets treated, especially for folks with immune system problems. It also highlights how important our immune system is for keeping viruses in check. 'This discovery could completely change how we think about the development, and consequently the treatment, of cSCC in people who have a health condition that compromises immune function,' said Andrea Lisco, M.D. , Ph.D., of NIH's National Institute of Allergy and Infectious Diseases (NIAID). 'It suggests that there may be more people out there with aggressive forms of cSCC who have an underlying immune defect and could benefit from treatments targeting the immune system.'
Time of India
3 days ago
- Time of India
NIH cuts spotlight a hidden crisis facing patients with experimental brain implants
Carol Seeger finally escaped her debilitating depression with an experimental treatment that placed electrodes in her brain and a pacemaker-like device in her chest. But when its batteries stopped working, insurance wouldn't pay to fix the problem and she sank back into a dangerous darkness. She worried for her life, asking herself: "Why am I putting myself through this?" Seeger 's predicament highlights a growing problem for hundreds of people with experimental neural implants, including those for depression, quadriplegia and other conditions. Although these patients take big risks to advance science, there's no guarantee that their devices will be maintained - particularly after they finish participating in clinical trials - and no mechanism requiring companies or insurers to do so. A research project led by Gabriel Lazaro-Munoz, a Harvard University scientist, aimed to change that by creating partnerships between players in the burgeoning implant field to overcome barriers to device access and follow-up care. But the cancellation of hundreds of National Institutes of Health grants by the Trump administration this year left the project in limbo, dimming hope for Seeger and others like her who wonder what will happen to their health and progress. An ethical quagmire Unlike medications, implanted devices often require parts, maintenance, batteries and surgeries when changes are needed. Insurance typically covers such expenses for federally approved devices considered medically necessary, but not experimental ones. A procedure to replace a battery alone can cost more than $15,000 without insurance, Lazaro-Munoz said. While companies stand to profit from research, "there's really nothing that helps ensure that device manufacturers have to provide any of these parts or cover any kind of maintenance," said Lazaro-Munoz. Some companies also move on to newer versions of devices or abandon the research altogether, which can leave patients in an uncertain place. Medtronic, the company that made the deep brain stimulation, or DBS, technology Seeger used, said in a statement that every study is different and that the company puts patient safety first when considering care after studies end. People consider various possibilities when they join a clinical trial. The Food and Drug Administration requires the informed consent process to include a description of "reasonably foreseeable risks and discomforts to the participant," a spokesperson said. However, the FDA doesn't require trial plans to include procedures for long-term device follow-up and maintenance, although the spokesperson stated that the agency has requested those in the past. While some informed consent forms say devices will be removed at a study's end, Lazaro-Munoz said removal is ethically problematic when a device is helping a patient. Plus, he said, some trial participants told him and his colleagues that they didn't remember everything discussed during the consent process, partly because they were so focused on getting better. Brandy Ellis , a 49-year-old in Boynton Beach, Florida, said she was desperate for healing when she joined a trial testing the same treatment Seeger got, which delivers an electrical current into the brain to treat severe depression. She was willing to sign whatever forms were necessary to get help after nothing else had worked. "I was facing death," she said. "So it was most definitely consent at the barrel of a gun, which is true for a lot of people who are in a terminal condition." Patients risk losing a treatment of last resort Ellis and Seeger, 64, both turned to DBS as a last resort after trying many approved medications and treatments. "I got in the trial fully expecting it not to work because nothing else had. So I was kind of surprised when it did," said Ellis, whose device was implanted in 2011 at Emory University in Atlanta. "I am celebrating every single milestone because I'm like: This is all bonus life for me." She's now on her third battery. She needed surgery to replace two single-use ones, and the one she has now is rechargeable. She's lucky her insurance has covered the procedures, she said, but she worries it may not in the future. "I can't count on any coverage because there's nothing that says even though I've had this and it works, that it has to be covered under my commercial or any other insurance," said Ellis, who advocates for other former trial participants. Even if companies still make replacement parts for older devices, she added, "availability and accessibility are entirely different things," given most people can't afford continued care without insurance coverage. Seeger, whose device was implanted in 2012 at Emory, said she went without a working device for around four months when the insurance coverage her wife's job at Emory provided wouldn't pay for battery replacement surgery. Neither would Medicare, which generally only covers DBS for FDA-approved uses. With her research team at Emory advocating for her, Seeger ultimately got financial help from the hospital's indigent care program and paid a few thousand dollars out of pocket. She now has a rechargeable battery, and the device has been working well. But at any point, she said, that could change. Federal cuts stall solutions Lazaro-Munoz hoped his work would protect people like Seeger and Ellis. "We should do whatever we can as a society to be able to help them maintain their health," he said. Lazaro-Munoz's project received about $987,800 from the National Institute of Mental Health in the 2023 and 2024 fiscal years and was already underway when he was notified of the NIH funding cut in May. He declined to answer questions about it. Ellis said any delay in addressing the thorny issues around experimental brain devices hurts patients. Planning at the beginning of a clinical trial about how to continue treatment and maintain devices, she said, would be much better than depending on the kindness of researchers and the whims of insurers. "If this turns off, I get sick again. Like, I'm not cured," she said. "This is a treatment that absolutely works, but only as long as I've got a working device."
Mint
4 days ago
- Mint
Vinay Prasad is a Bernie Sanders acolyte in MAHA drag
Meet Vinay Prasad, a young disciple of Bernie Sanders who ranks as one of the most powerful officials in the federal government. He determines whether patients get access to many life-saving medicines. Or not. Think of him as a one-man death panel. Dr. Prasad was named by Marty Makary, the Food and Drug Administration commissioner, as head of the agency's biologics division in May, and last month as its chief medical and scientific officer. More on why he was tapped to these posts later. But it isn't an exaggeration to say that Dr. Prasad wields more power than Anthony Fauci ever did at the National Institutes of Health. Like Dr. Fauci, Dr. Prasad thinks he knows what's best for people, and that it's government's job to make it happen. 'I favor a strong regulatory state," he proudly professes. And just as Dr. Fauci slowed experimental HIV treatments during the 1980s by rigidly adhering to strict trial protocols, Dr. Prasad is now scuttling potentially life-saving therapies. In recent weeks, the FDA has rejected three therapies for debilitating diseases that have shown promise in clinical trials. The agency has also forced off the market a gene therapy that can slow the degenerative loss of muscular function in young boys with certain genetic mutations. Behold America's strong and arbitrary regulatory state at work. If you read Dr. Prasad's paper—or follow his smash-mouth Substack and feeds—the FDA's recent actions are no surprise. Dr. Prasad has long criticized the FDA for approving too many treatments that, in his view, provide only marginal benefits. He's also lambasted President Trump's first-term 'right to try" law, which lets terminally ill patients try experimental drugs not yet approved by the FDA. 'It is crucial to question whether non-curative therapies . . . are worth it," Dr. Prasad wrote in a 2021 paper about an FDA-approved cell therapy for multiple myeloma. The therapy reduced disease progression or death by half in patients with advanced cancers who hadn't responded to already approved therapies. Impressive. But Dr. Prasad complained that the treatment was pricey (then $419,500 for a course) and may 'only delay inevitable progression" in some patients. In other words, sick patients should just give up and die. Got that? In 2016 he wrote an op-ed titled 'The case for rationing: Why we should limit public spending on cancer drugs." He exalted the United Kingdom's socialized health system for restricting access to new treatments until they demonstrate a high degree of efficacy in multiple trials and that their benefits—as determined by the government—exceed their costs. Such government rationing is why survival rates for hard-to-treat cancers are much lower in the U.K. than in America—and why British patients with the financial means cross the pond to receive innovative and often life-saving treatments. Tough luck to Brits of average means. Of course, Dr. Prasad insists he really has patients' best interests at heart. Why would terminally ill patients want to waste their precious remaining time on earth schlepping to hospitals for treatments that may not cure them when they could be preparing for their deaths? That's the gist of his 2022 paper, which estimated patients with advanced cancers spend 16 more hours a month accessing and receiving novel treatments than if they accepted hospice or home palliative care. 'Time is a valuable resource for people who have cancer," the paper noted. Yes, and that's why they want to continue living. He has also argued that 'genome-informed cancer medicine"—treatments targeted based on a patient's genes or tumor mutations—'is mostly hype," no matter that such treatments have produced most recent improvements in cancer survival. Take CAR T-Cell therapies that re-engineer a patient's immune cells to target proteins on tumor cells. Such therapies can cure aggressive cancers that not long ago carried a death sentence, though Dr. Prasad has hyped their side effects. He has done the same for Sarepta Therapeutics' Duchenne muscular dystrophy gene therapy, which the agency this month forced off the market after two patients in the advanced stages of the disease died from apparent side effects. The deaths look to have been a pretext for Dr. Prasad to deep-six the drug, which he had previously criticized as too costly for its benefits. Most treatments carry rare, life-threatening side effects, but doctors and patients can weigh their risks against their benefits. Perhaps Dr. Prasad doesn't trust people to do so any more than Dr. Fauci did. Dr. Prasad found common cause with Dr. Makary and conservatives in opposing paternalistic Covid policies including vaccine mandates and school shutdowns. But his other positions are at odds with Dr. Makary's stated support for more flexible reviews of drugs that treat rare and deadly diseases and the MAHA ethos of patient empowerment. Dr. Makary in spring 2021 lambasted the FDA for using the 'eternal excuse of safety" to pause the Johnson & Johnson Covid vaccine after a rare blood-clotting side effect cropped up, mostly in middle-aged women. 'This is a life-saving medication," he then wrote. 'What ever happened to giving people the data and letting them make their own health decisions?"
